Clinical Trial Update: A Novel Strategy For Personalized Long-Term Dual Antiplatelet Therapy (RAPID EXTEND PILOT STUDY) [Phase 4]

View source ↗

Summary

Phase 4 trial update on a personalized long-term dual antiplatelet therapy strategy (RAPID EXTEND PILOT STUDY) terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stable Coronary Syndrome

Drugs mentioned

• TICAGRELOR (ticagrelor)

Snippet

Sponsor: Ottawa Heart Institute Research Corporation | Conditions: Stable Coronary Syndrome, Percutaneous Coronary Intervention | Phase 4 | Status: TERMINATED